BSF Enterprise Plc (LON:BSFA)
London · Delayed Price · Currency is GBP · Price in GBX 0.9500
+0.0750 (8.57%)
Mar 30, 2026, 10:12 AM GMT
BSF Enterprise Company Description
BSF Enterprise Plc, together with its subsidiaries, develops and commercializes cell-based tissue engineering solutions in the United Kingdom and Hong Kong.
The company acquires businesses in the biotechnology, marketing, and e-commerce sectors. It also engages in biotechnology start-up; lab-grown cornea and meat research; and development of skin technology.
The company was incorporated in 2018 and is based in London, the United Kingdom.
BSF Enterprise Plc
| Country | United Kingdom |
| Founded | 2018 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 14 |
| CEO | Che Connon |
Contact Details
Address: 2 Portman Street London, W1H 6DU United Kingdom | |
| Website | bsfenterprise.com |
Stock Details
| Ticker Symbol | BSFA |
| Exchange | London Stock Exchange |
| Fiscal Year | October - September |
| Reporting Currency | GBP |
| ISIN Number | GB00BHNBDQ51 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Che John Connon | Chief Executive Officer, MD and Executive Director |
| Geoffrey Robert Baker B.Com., L.L.B., M.B.A. | Executive Chairman |
| Graham John William Duncan | Chief Financial Officer |
| Ricardo Gouveia | C.S.O |
| Marcelo Bravo | Chief Business Officer |